current user: public




Query: TM1651 TM1651 283508 Purified-2001-12-11, from JCSG0516

Results of FFAS03 search in COG0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680
# Score Template Links and tools%idFirst MGGLQNVRSAALIGHNGSGKSLLLAQILYKSGLIDKADTKYVDYDPVEEEKGASFSSHVASLEWKGKKVYLIDTPGFSDFISEVINGIFVSENIISVVNAVAGVEIQTERTWNMADEMKKPIIVFVNQMDKERANFENVVAELKERFSRKIVPVVVPIGAAENFEGVVDLLKKKAYRYDGDKVQEEDMPESFNDMRSEILEDIVEQDEELMMRYLDGEDIGYDELMRVLKEGYKKGEIVPVLSGSALKGIGLDLLLDYLGDIGVSPEEAPSYKALLEDGTEIEVKFSEEEPFCAYIFKSVVDQFVGRITFAKVIAGVLRPGDTVVNVQKDVTEKVGHVYVPILKQQKEVESAGPGEIVVLLKLKEGAVGETLAHRDRRVKIVPPAFPEPMFSRSVHPKSKSDIDKISSGLSRLSDSDPTFVWEYDPETGETVVSGLGAMHLDVMIERLKKIFGVDVEVGKPKIAYRETITTTAVAEHKHKKQTGGHGQYGHVKIQLEPLPRGQGYEFVDKIVGGVIPRNFIPSVDKGIREAMKKGVLAGYPVTDVRVILFDGSYHEVDSSDISFQIAAIQAFKKGMEAAKPVILEPIMEVEVFVPEENAGDVMGEISSRRGRPLGMEPSGKGMVKVKAEVPLAEMLDFSSKLSSITSGRGYFTMRFQRYEIVPPNIQEKIIEERRREMQEQEKLast
1 -199.000[J] COG0480 Translation elongation factors (GTPases)  ali follow..  39  5.NPLEKVRNIGIAAHIDAGKTTTTERILFYSGIIHKIGEVHTDWMDQERERGITITAAAISTSWKDYQINIIDTPGHVDFTIEVERSMRVLDGVIAVFCSVGGVQPQSETVWRQADRYKVPRIAFINKMDRTGANFYRVHEQMRDRLRANAIAIQLPIGSENDFKGIVDLVRKRAYMYNGTDIEETDIPADLEEYYTKLVEAVAETDDDLMSKYFDGEPLTEEEIRSALRKGTIAGTIVPVLCGSAFKNKGVQLMLDAVVDYLPAPTEVPPIQGTLPNGDAIERRADDNEPLAALAFKIMADPY-GRLTFVRVYSGVLKKGSYVLNATKNKKERISRLVLMKADDRQDVEELRAGDLGAALGLKDTLTGDTITDEGAPVILESLFIPEPVISVAVEPKTKNDMDKLSKALQSLSEEDPTFRVNVDPETNQTVIAGMGELHLEILVDRMLREFKVEANVGAPQVAYRETIRKPVNVEGKFIRQSGGKGQYGHVVINLEPGEPGTGFEFVSKIVGGVVPKEYIGPAEQGMKESCESGILAGYPLIDVKATLVHGSYHDVDSSEMAFKIAGSMALKEAVLKASPVLLEPMMKVEVEVPEDYIGNVIGDLISRRGQIESQSTEQ-GLAKVASKVPLATMFGYATDIRSKTQGRGIFTMEFSHYEEVPRSVAETIIAKSKGNA..... 692
2 -177.000[J] KOG0465 Mitochondrial elongation factor  ali follow..  30  65.GRCNKLRNIGISAHIDSGKTTFTERVLYYTKRIKAIHEVRMDSMDLEREKGITIQSAATYCSWKNYHFNLIDTPGHIDFTIEVERALRVLDGAVLVVCAVSGVQSQTVTVDRQMRRYNVPRVTFINKMDRMGSDPFRAIEQLNSKLKIPAAAVQIPIGSESSLSGVVDLINRVAIYNKGEIIEKGPVPENLEEKRQLLIETLADVDDEMAEMFLEEKEPTTQQIKDAIRRSTIARSFTPVLMGSALANTGIQPVLDAIVDYLPNPSEVLNTALDVSNNEKVNLVPAVQQPFVGLAFKLEEGKY-GQLTYVRVYQGRLRKGNYITNVKTGKKVKVARLVRMHSSEMEDVDEVGSGEICATFGI-DCASGDTFTDGSVQYSMSSMYVPDAVVSLSITPNSK-DASNFSKALNRFQKEDPTFRVKFDPESKETIISGMGELHLEIYVERMRREYNVDCVTGKPQVSYRESITIPADFDYTHKKQSGGAGQYGRVIGTLSPVDDTKGNIFETAIVGGRIPDKYLAACGKGFEEVCEKGPLIGHRVLDVKMLINDGAIHAVDSNELSFKTATMSAFRDAFLRAQPVIMEPIMNVSVTSPNEFQGNVIGLLNKLQAVIQDTENGH-DEFTLKAECALSTMFGFATSLRASTQGKGEFSLEFSHYAPTAPHVQKELISEFQKKQAKK.. 761
3 -71.200[J] KOG0469 Elongation factor 2  ali follow..  22  17....RNIRNMSVIAHVDHGKSTLTDSLVSKAGIIAG-ETRFTDTRKDEQERCITIKSTAISLFFNGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLFMNKMDRALLEFQRIVENINVIIATMVDPSIGNVGFGSGLHGWAFTLKQFAEMYAGKDESKRGFCQFVLDPIFMVFDAVMNIKKDKTAALVEKLGIKLANDEKDLEGKPLMKVFMRKWLPAG------DTMLQMIAFHLPSPVTAQKYRPHDDEAAVAIKTCDPNGPLMMYISKMVPTSDKGRYAFGRVFSGKVATGMKARKKEDLYEKTIQRTILMMGRFIEPIEDIPSGNIAGLVGVDQYLVKGTITTYKDAHNMRVMKFVSPVVRVAVEAKNPADLPKLVEGLKRLAKSDPMVQCIFE-ESGEHIIAGAGELHLEICLKDLEEDHCIPLKKSDPVVSYRETVQSESNQI-----LSKSPNKHNRLHCTAQPMPDG----LMDVTKGVQYLNEIKDSVVAGFQWATREGVLSDENMRGVRFNVHDVTLHADAIHRGGGQITARRVFYASVLTAEPRLLEPVYLVEIQCPEAAVGGIYGVLNRRRGHVFEESQVGTPMFVVKAYLPVNESFGFTADLRSNTGGQAFPQCVFDHWQVLPGTKPNQIVLDTRKRKGLKEG 841
4 -67.100[J] KOG0468 U5 snRNP-specific protein  ali follow..  20  129....PLIRNVALVGHLHHGKTTFVDCLIRQTHPQFETMEEYTDTLFTEQERGCSIKATPVTLVLKSYLLNIFDTPGHVNFSDEATAAMRMSDGVVLFIDAAEGVMLNTERLLKHAVQERQAITVCINKIDRLILELKHIVEEVNGLLSTLVSPILGNVCFASSLYGFCFTLKSFAKLYADTNSAQRSFVEFILEPMYKLIAQVVGDVDTTLSDTLAELNVRVSKEEMKSNIRPLLRLVCNRFMGDC------SGFVDMCVEHIKSPLENAKRKPKEGDIYRDMISCNQYGTLMVHSSKMYPNDDCTFFVLARIVSGTLHAGQEVRDEEDSRILQVGRLWVFESRYKVELNRVPAGNWVLIEGIDQTSTIVDINVPEDLYIFRPLKFTQSIIKIAVEPVNPSELPKMLDGLRKVNKSYPLLSTRVE-ESGEHVILGTGELYLDCVMHDLRKMYEIDIKVADPVVAFCETVVETSSLKCFAETPN----KKNKITMISEPLEKG----LVDDTLPSEVDKNLLTAVKQGFQWGTREGPLCEEPIRNVKFKILDGVIANEALHRGGGQITARRVAYSAFLMATPRLMEPYLFVEVQAPADCVSAVYTVLARRRGHVTQDAPVGSPIYTIKAFIPAIDSFGFETDLRTHTQGQAFCLSVFHHWQIVPGDPLDKSIIIRPLEPQQASH 931
5 -56.900[J] COG4108 Peptide chain release factor RF-3  ali follow..  20  11..EVSKRRTFAIISHPDAGKTTITEKVLLFGRAIQVAGTVKSDWMEMEKERGISVTTSVMQFPYGDCLVNLLDTPGHEDFSEDTYRTLTAVDSCLMVIDAAKGVEDRTRKLMEVTRLRDTPIVTFMNKLDREIRDPMELMDEVENELKIACSPITWPIGCGKEFKGVYHIHRDETILYTSGQGHTIQEERIIKGLDNPELDQAV--GADLAAQLREELELVLGASHEFDRELFLQGELTPVFFGTALGNFGVDHMLDGLTQWAPSPMPRQAAERVVE---------ASEEKFTGFVFKIQANKHRDRIAFVRIVSGTYKQGMKMNHVRLGKQVNISDAVTFMAGDRARAEEAFAGDIIGLHNHGTIQIGDTFTQ-GETLKFTGIPNFAPELFRRIRLRDPLKQKQLLKGLVQLSEEG-AVQVFRPLQNNDLIVGAVGVLQFDVVVSRLKSEYNVEAIYEGVNVATARWVECDDVKK............................................................................................................................................................................................................... 483
6 -49.500[T] COG1217 Predicted membrane GTPase involved in stress response  ali follow..  23  2...IENLRNIAIIAHVDHGKTTLVDKLLKLSGTKEAESERVMDSNDQEKERGITILAKNTAIKWNGYNINIVDTPGHADFGGEVERVMSMVDSVLLVVDAQDGPMPQTRFVTQKAFKAGLRPIVVVNKIDRPGARPDWVIDQIFDNLGATDEQLDFPIVYASALNGIAGL-------------------------------------------------------------------------DHEKMDDNMDALFQAIIDHVPAP------------------VVDTEGPFQMQISQLDYNSFLGVIGIGRITRGKVKSNTPVVAISDDRNGRILKIMGHHGLQRVEVAEAEAGDIVCVSGMEELFISDTLCDPQNVEALPPLTVDQPTVSMTFQVNDSPTSRNIKERLEKELLHNVALRVEPGDSPEKFKVSGRGELHLSVLIETMRRE-GFELAVGRPEVVIIEK---------------------------------------------------------------------------------------------------------------DGEKQEPYENVTIDIEEQHQGSVMEQMGLRKGDLSNMIPDGKGRVRLEYTIPARGLIGFRNNFLTLTSGTGILTSTFSHYGPI..................... 475
7 -46.400[J] KOG0462 Elongation factor-type GTP-binding protein  ali follow..  25  37.FTPDKIRNFGIVAHVDHGKSTLADRLLEMCGAVPPGQKQMLDKLQVERERGITVKAQTAALRHRGYLLNLIDTPGHVDFSAEVSRSLAVCDGILLLVAANQGVQAQTIANFWLAFEKNIQIIPVINKIDLPGADIKSVETQLKNLFE-------------------------------------------------------FNPEECLH---------------------------------SAKSGLNVDKVLEAIIDRVPAP------------------TAIIDAPFRSMIFDSYFDHFRGAIAHIMVKEGSVKKGDKIQSYQNEKVYDVSEV--VMRPEMVKCTELRAGQVGYLVTVNEAVVGETLFAETTS--FAEIKGVKPTVYAGLFPVETSDYESLKQAVERLCLNDPSVTV--IPDSSKALGLGLGVLHMEVFGARLSQEYDASVILCQPSVEY--------------------------------------------------------------------------------RAKIKDNETIRKKRYDGMEEIRILDPSKFPDESDVDSFLEPMVKVRMIVPNEMMGTVNGLCSECRGERGEITSIDSTRLVILWRLPLAEVVDFFERLKKLTSGYASFDYEPDGWQDTRLVKLTILINSKEVSE..... 539
8 -41.700[M] COG0481 Membrane GTPase LepA  ali follow..  24  1...MKNIRNFSIIAHIDHGKSTLSDRLIQTCGGLREMEAQVLDSMDLERERGITIKAQSVTLNYKTYQLNFIDTPGHVDFSYEVSRSLAACEGALLVVDAGQGVEAQTLANCYTAIEMNLEVVPILNKIDLPAADPERVAEEIEDIVG-------------------------------------------------------IDAMEAVR---------------------------------SAKTGVGIEDVLEEIVHKIPAP------------------EGDPNAPLQALIIDSWFDNYLGVVSLVRIKNGTLRKGDKIKVMSTGQSYNVDRL--IFTPKQVDTTILNCGEVCAIKDILGAPVGDTLTSHNNPASLPGFKKVKPQVYAGLFPISSDDYEAFRDALGKLSLNDASLFY--EPENSTALGFGLGLLHMEIIQERLEREYDLDLITTAPTVVY--------------------------------------------------------------------------------EVEKTDGEVIYVDSPSKLPPLNNITEIR-----------EPIAECNMLLPQTYLGNVITLCVEKRGVQTNMVYHGN-QVALTYEIPMGEVLDFFDRLKSTSRGYASLDYGFKRFQAADMVRVDIMINGERVDA..... 494
9 -18.100[J] KOG0460 Mitochondrial translation elongation factor Tu  ali follow..  20  55........NIGTIGHVDHGKTTLTAAILSDLGQASFMDYSQIDKAPEEKARGITISSAHVEYETANRHYAHVDCPGHADYIKNMITGAATMDGAIIVVSATDGQMPQTREHLLLARQVGVKQIVYINKVDMV--------------------------------------------------------------------------EPDMI-------ELVEMEMRELLSEYGFDGDNTPIVSGSALCLNSITKLMEAVDSYITLP------------------ERKTDVPFLMAIEDVFSISGRGTVVTGRVERGTLKKGAEI--------EIVG---------GSHLKTTVTGIEMFKKQLDAAVAGDNCGLLLRSIKREQLK------MIVAQPGTVAPHQKFKASFYILTKEEPQLYSRTSDVTVELTHPDPND--------------SDKMVMPGDNVEMICTLIHPIVIE-RFTVREGGS..................................................................................................................................................................................................... 427
10 -18.100[J] KOG0458 Elongation factor 1 alpha  ali follow..  15  169........SFVVLGHVDAGKSTLMGRLLYDLNIVNQMGKSSMDQTNEERERGVTVSICTSHFSTHRANFTIVDAPGHRDFVPNAIMGISQADMAILCVDCSTNLDGQTKEHMLLASSLGIHNLIIMNKMDNVD--------------------------SQQRFEEIKS-----------------------------------------LLPYLVDIGFFEDNI-----------NWVPI-SGFSGEGVYKIEYTDEVRQWYNGPNLMSTLENAAFKISKENEGINKDDPFLF-IIPSKKTSNDLALVSGKLESGSIQPGESLTIYPSEQSCIVDKI-QGQSTNHEETDVAIKGDFVTLAYPEDIQNGDLAASVDYSSIHSAQCFVLELTPFILFIGVKEQPARIKRLISFI-------KGNTASKKKIRHLGSKQRAFVEIELIEVKRWIPLLTAHENDRLG-RVVLRKDGRT................................................................................................................................................................................................................ 600
11 -17.700[J] KOG1145 Mitochondrial translation initiation factor 2 (IF-2; GTPase)  ali follow..  16  183.........VTIMGHVDHGKTTLLDKFRKTQVAAVETG-------------GITQHIGAFLVS-SGEKITFLDTPGHAAFSAMRARGAQVTDIVVLVVAADDGVMKQTVESIQHAKDAQVPIILAVNKCDKAEADPEKVKKEL--------------------------------------------------------------LAYDVVCEDYGGDVQAVP---------------------SALTGDNLMALAEATV-----------------LAEMLELKADPNGPVEGTVIESFTDKGRGLVTTAIIQRGTLRKGSVLVAGKC-----WAKVRLMFDENGKTIDEAYPSMPVGITGWRDLSAGEEI------LEVESEPRAREVVDWRKYEQEQEKGQEDLKIIEEKRKEHKEAHQKAREKYGHLLWKKRSILRFLERKEQIPLKPKRERDSNVLSVIIKGDVDGSVEAILNIIDTYDASHE-----CELELVHFGVGDISANDVNLAETFDGVI--YGFNVNAGNVIQQSAAKKGVKIK--LHKIIYRLVEDLQEELS-----------------RLPCAVEEHPVGEASILATFSVTEGKKKVPVKGQLEKQKKFKLTRNGHSLTSLKHHKDDISIVKTG................................... 689
12 -16.300[J] COG0050 GTPases - translation elongation factors  ali follow..  22  14........NVGTIGHVDHGKTTLTAAILAKTYGGSARAFDQIDNAPEEKARGITINTSHVEYDTPARHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIVFMNKCDMVD-------------------------------------------------------------------------DEELL-------ELVEMEVRELLSAYDFPGDDLPVVRGSALKEAKIIELAGYLDSYIPEP------------------ERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIVKVGEEV--EIVGIKDTVKSTCTGVEMFRKLLDEGRAGENVGVIKREDIERGQVLAKPG-----------------SIKPHTTFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTVTGTIELPEGVEMVMPGDNINMIVTLIHP-IAMDDGLRFAIREGGR----TVGAGVVAKV............................................................................................................................................................................................... 392
13 -15.700[J] KOG0459 Polypeptide release factor 3  ali follow..  18  103........NVVFIGHVDAGKSTIGGQILFLSGQVDD--AYIMDTNEEERLKGKTVEVGRAHFETESTRFTILDAPGHKSYVPNMISGASQADIGVLVISARKGFETGYERGGQTREHVQLAKIVVVNKMDDPTVNWSKEYDEIEQKMV--------PFLKASGYNTKKDVVFLPISGLMG--------------------KNMDQRMGQEICPWWSGPSFFE------------------------------------VLDSIEIP------------------PRDPNGPFRMPIIDKFKD--MGTVVMGKVESGSIREGDSLVVMPNKEQVKVVAIYC----DEDKVKRAGPGENLRVIEDEDILSGFVLSSIVNPLQILELLDNAIF-AVVEECEIIELKSQIDLKTRKPMKKKVLF------KNGAAVVCRI-QVTNSICIEKFS.......................................................................................................................................................................................................................................... 500
14 -15.500[J] KOG0052 Translation elongation factor EF-1 alpha/Tu  ali follow..  18  9........NIVVIGHVDSGKSTTTGHLIYKCGGIDK--AWVLDKLKAERERGITIDIALWKFETAKYYITIIDAPGHRDFIKNMITGTSQADCAVLVVACGTG-NGQTREHALLAQTLGVKQLIVCNKMDSTEPPF-----------------------SEARFTEITNEVSIKKIGYNPKAVPFVPISG------------------------FNGDNMLEVSSNMPWFKGWAVERKEGNASGKT--------LLEALDSIIPPQRPT-------------------DRPLRLPLQDVYKIGGIGTVPVGRVETGIIKPGMVVTFAPQNVTTEVKSVEM----HHESLPEAVPGDNVGFVSVKDIRRGSVCSDSKQDPAKEARTFHAQVIIM---------------------------------NHPGQISNGYTPV--------------LDCHTAHIACKFNELKEKVDRRTGKKVEDFPKFLKSGDAGI------------------------ELIPTKPLCVESFTDYAPLGRFAVRDMRQTVAVGVIKSVEKSDGSSGKVTKSAQKAAPKK......................................................................................................... 462
15 -14.800[J] COG3276 Selenocysteine-specific translation elongation factor  ali follow..  17  3.........IVTSGHVDHGKTALLKAL---TG-------TSTAHLPEEKKRGMTIDLGYAYLPLENKVLGFIDVPGHEKFLSNMLAGLGGVHYAMLIVAADEGVAVQTKEHLAILRQLQFHEIVVITKADRTNSAQI-------------------------------------------------------------------------------------ESLIQTIKQDYSFLRNANYFVTSAETGQGISELRHYL--------------------ANLAELADTQKPFRYAIDRVFSVKGAGTVVTGTAFSGTVKVNDEIY-LSTGQKIRIKAIHA----QNTSSEQGIAGNLNADLDRTPMKRGDWLLQNEPLPPTDRIS----VQILAEVPLNESQPVHIYHGASRTTGK-----TLLQGKNAAKNDRTLAEIILDSPLDKILRSGDTKTLIAGARV............................................................................................................................................................................................................................ 340
16 -14.600[J] COG0532 Translation initiation factor 2 (IF-2; GTPase)  ali follow..  20  448.........VTIMGHVDHGKTTLLDRFRESRVTEGEAG-------------GITQHIGAYQIKANGKKITFLDTPGHEAFTSMRARGASVTDITILVVAADDGVMPQTIEAINHSKAAGVPIIVAINKIDKPGANPQRVTQEL--------------------------------------------------------------TEHGVFPVAWDPE---------------NGSEFVEI---SAKFNQNLDELLDTVL-----------------VAEVQELKADPTVRAIGTVVEARLDQGKGAIATLLVQQGTLHVQDPIVVGNT-----YGRVRTMTNDLGRRIKEAGPSTPIELTGLSDVQAGDHF-QNTRRVNLDNL------VNIIIKADVQGSAEALAASLQKIEVEGVKVDI---------VHSAVGAIESDISLAAASNAIIIGFNVRPTGLAREQAAQEEVDIR------------HSIIYKVIEEVETA---EFKEEIIGEAIVRETF--------NVSKVGTIAGFMVIRGKVAIHDGAIASLDVKEVGNAQEGGLMVEDFNDVEIDDTFEVYKMVEI........................................................................................... 941
17 -13.900[J] COG5256 Translation elongation factor EF-1alpha (GTPase)  ali follow..  17  12........NLITIGHVDHGKSTLVGRLLYEHGEIPA--AWVMDRFKEERERGVTIDLAHRKFETDKYYFTLIDAPGHRDFVKNMITGTSQADAAILVISAREGVMEQTREHAFLARTLGVPQMVVINKMDATSPPY-----------------------SEKRYNEVKADAEKLLRSIGFKDISFVPISGYKGDNVTKPSPNMPWYKGPTLLQALDAFKVPEKPINKPLRIPVED------------------------------------------------------------VYSITG---IGTVPVGRVETGVLKPGDKVIFLPADKQGDVKSIEM----HHEPLQQAEPGDNIGFIAKNDIKRGDVCGHLDTPPTVVKAFTAQIIVTAQVACRIDEIVKTLNPKDGTTLKEKPDFIKNGD.................................................................................................................................................................................................................................................................. 381
18 -13.500[J] COG5257 Translation initiation factor 2, gamma subunit (eIF-2gamma; GTPase)  ali follow..  16  8........NIGLVGHVDHGKTTLTKAL----------SGVWTDTHSEETKRGISIRLGYADITFRKRKVSFVDAPGHETLMATMLSGAALMDGAILVIAANEPCQPQTKEHLMALDVIGVKDIVVQNKIDI---------------------------------------------------VSKERALESYREIKEFVKGTCAED--------------------------------APIIPVSAQQGANIDILIETIEERIKTP----------KRDVDKPARMYVARSFDINKPGADPEHLAGGVIGGSLVQGRLRVGDEI-KDGKQTWMSLHSTITGLVAGGEEMEEVGPGGLVGVLTKADSLSGSVAGEPGTPPVRHSFTMETHLLERVVGTKEETKVEPIKTG------EPLMINVGTTTTVGVVKSARADDADVVLACAEEGQRIALSRRVGA............................................................................................................................................................................................................................... 397
19 -13.400[J] KOG0466 Translation initiation factor 2, gamma subunit (eIF-2gamma; GTPase)  ali follow..  14  43........NIGTIGHVAHGKSTVVKAI----------SGVHTVRFKNELERNITIKLGYANAK---RHVSFVDCPGHDILMATMLNGAAVMDAALLLIAGNESCQPQTSEHLAAIEIMKLKHLILQNKIDL---------------------------------------------------VKERQAKEQYEQILAFVQGTVAEG--------------------------------APIIPISAQLKYNIEVVCEYIVKKIPVP----------PRDFTSEPRLIVIRSFDVNKPGCEVDDLKGGVAGGSILKGVLKVGQET-SEGKLMCKSIFSKIVSLFAEHNDLQYAAPGGLIGVLCRADRMVGQILGAVGAPEIFTELEISYFLLRRLLGVRTEGDKK--AAKVQKLSKNEVLMVNIGSLSTGGRVSAVKADL--------------GKIVLTNPEVGEKIALSRRVEKHWRLI----GWGQIRRG-VTIKPTVDDD.................................................................................................................................................................................... 472
20 -12.100[E] COG4917 Ethanolamine utilization protein  ali follow..  15  1......MKRIAFVGSVGAGKTTLFNALQGNYTLARKTQAVEF------------------------NDKGDIDTPGEYFNHPRWYHALTLQDVDMLIYVHGANDPESRLPAGLLDIGVSKRQIAVISKTDMPDADVAATRKLLLETGFEEPM---FELNSHDP-QSVQQLVDY.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 141
21 -11.600[P] COG2895 GTPases - Sulfate adenylate transferase subunit 1  ali follow..  16  25....KSLLRFLTCGSVDDGKSTLIGRLLHDTRQIYRHGTQLVDGLQAEREQGITIDVAYRYFSTEKRKFIIADTPGHEQYTRNMATGASTCELAILLIDARKGVLDQTRRHSFISTLLGIKHLVVINKMDLVDYS-EETFTRIREDYLTFA----------GQLPGNLDIRFVPLSALEGDNVASQS-------------ESMPWYSGPTLLEVLETVEIQRVVDAQPMR-----------------------------VQYVNRP----------------------------LDFR-----YAGTLA-----SGRVEVGQRVKVLPSGVESNVARIVTFDG----DREEAFAGEAITLV---DISRGDLLLAADEALPAVQ-SASVDVVWMAEQPLSPGQSYDIKIAGKKTRARVDGIRYQVDINNLTQRLNGIGLVDLTFDEPLVLDRYQQNPVTGGLIFIDRLS....................................................................................................................................................................................................................... 425
22 -11.300[R] COG5258 GTPase  ali follow..  17  109........TVVALGNVDAGKSTLVGVLTLDDGKGLARSYASRYKHEVLTGRTSAVSLRLLVYKRSDKLVLLVDVGGHERYLRTALRGLSQPDYVMLVVAANSGVQKMTKEHLGIAVAIGIPVFVVVTRIDITP-------------------------------------------------------SEVFQKTVEEVVRILKMPGVSKIPYIIKDTNDVVLA-----AKAMPAGRVAPVFYVSSVTGHGLD-LLLRFLSLLPRR-----------------RRWDYGGEFLMYISDIYLVKGVGVVIGGLVEKGILHVGDRVWLGPYSDGKWMQTVVKSIHFNRTPVESAKAGSFITVAKVEKVEKGMVLSARP----------LKAVREVTADVLVLRHPTVIRAGFS------GVFHYKAVRTGGYIKEIDKGELM-----GVVKIELSRPWHIDSGVFVFRN........................................................................................................................................................................................................................ 499
23 -10.200[U] KOG0090 Signal recognition particle receptor, beta subunit (small G protein superfamily)  ali follow..  18  53....TKSNTVLLSGLSGSGKTVLFYQLRDGSSHQGAVTSM------EPNEGTFVLHNENNTKKGKVKPVHLIDVPGHSRLISKLEEYLPRAAAVVFVVDALENIRAASEYLYDSVIKNKTPVLLCCNKTDKVTA---HTKEFIRKQMEKEIDKLRVSRSAISTADIANDFTLGI----EGEVFSFSHCHNKVTVAEASGLTGETDQVQEFIREHVK................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 259

FFAS is supported by the NIH grant R01-GM087218-01
8 5 8 8 9   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Ye Y, Godzik A. Comparative analysis of protein domain organization. Genome Res. 2004 Mar;14(3):343-53.